April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Objective Assessment of Visual Function in Patients Receiving Anti-Angiogenic Treatment for Wet Macular Degeneration: A Longitudinal Study
Author Affiliations & Notes
  • H. A. Baseler
    Psychology, University of York, York, United Kingdom
  • A. Gouws
    Psychology, University of York, York, United Kingdom
  • M. Crossland
    Institute of Ophthalmology, University College, London, United Kingdom
  • C. Leung
    Hull-York Medical School, Hull, United Kingdom
  • A. Tufail
    Institute of Ophthalmology, University College, London, United Kingdom
  • G. S. Rubin
    Institute of Ophthalmology, University College, London, United Kingdom
  • A. B. Morland
    Psychology, University of York, York, United Kingdom
  • Footnotes
    Commercial Relationships  H.A. Baseler, None; A. Gouws, None; M. Crossland, None; C. Leung, None; A. Tufail, None; G.S. Rubin, None; A.B. Morland, None.
  • Footnotes
    Support  Medical Research Council, UK
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 4380. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H. A. Baseler, A. Gouws, M. Crossland, C. Leung, A. Tufail, G. S. Rubin, A. B. Morland; Objective Assessment of Visual Function in Patients Receiving Anti-Angiogenic Treatment for Wet Macular Degeneration: A Longitudinal Study. Invest. Ophthalmol. Vis. Sci. 2010;51(13):4380.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To use functional MRI as an objective, fixation-independent measure of topographic visual function and assess cortical responsivity in patients undergoing anti-angiogenic treatment for wet age-related macular degeneration (AMD).

Methods: : Patients with bilateral neovascular AMD were scanned using functional MRI before and at regular intervals while undergoing treatment with intravitreal anti-angiogenic injections (primarily LucentisTM). Blood oxygenation level-dependent (BOLD) signals were measured in the brain while patients viewed a visual stimulus consisted of a full-field flickering (6 Hz) white light alternating with a uniform gray background (18 sec on, 18 sec off). Topographic distribution and magnitude of activation in visual cortex were compared within individuals longitudinally throughout the treatment period (<1 year) and with control patients not currently undergoing treatment.

Results: : The area of visual cortex activated increased significantly after the first treatment to include more posterior cortex that normally receives inputs from lesioned parts of the retina. Subsequent treatments yielded no significant further increase in activation area; however, activation magnitude continued to increase. Untreated patients showed a consistent lack of significant response in the cortex representing retinal lesions.

Conclusions: : Retinal treatments may improve vision but also result in a concomitant improvement in fixation stability. Current clinical behavioural measures (e.g. acuity, perimetry) are largely dependent on fixation stability, and therefore cannot separate improvements of visual function from fixation improvements. Functional MRI, which provides an objective and sensitive measure of visual function independent of fixation, reveals a significant increase in visual cortical responses in wet AMD patients following treatment with anti-angiogenic injections. Despite recent evidence that visual cortex degenerates subsequent to retinal lesions, our results indicate that it remains responsive as its inputs are restored.

Keywords: age-related macular degeneration • neuro-ophthalmology: cortical function/rehabilitation • imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×